111 Inc (YI)
1.01
-0.04
(-3.81%)
USD |
NASDAQ |
Apr 25, 16:00
1.00
-0.01
(-0.99%)
After-Hours: 20:00
111 Gross Profit Margin (Quarterly): 5.20% for Sept. 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 5.20% |
| June 30, 2023 | 5.98% |
| March 31, 2023 | 6.39% |
| December 31, 2022 | 6.11% |
| September 30, 2022 | 6.03% |
| June 30, 2022 | 6.32% |
| March 31, 2022 | 6.46% |
| December 31, 2021 | 5.91% |
| September 30, 2021 | 4.96% |
| June 30, 2021 | 4.45% |
| March 31, 2021 | 4.46% |
| December 31, 2020 | 3.92% |
| September 30, 2020 | 3.81% |
| Date | Value |
|---|---|
| June 30, 2020 | 5.23% |
| March 31, 2020 | 5.56% |
| December 31, 2019 | 3.15% |
| September 30, 2019 | 4.26% |
| June 30, 2019 | 5.02% |
| March 31, 2019 | 5.07% |
| December 31, 2018 | 4.15% |
| September 30, 2018 | 3.13% |
| June 30, 2018 | 6.11% |
| March 31, 2018 | 12.45% |
| December 31, 2017 | 8.07% |
| September 30, 2017 | 10.02% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
3.15%
Minimum
Dec 2019
6.46%
Maximum
Mar 2022
5.18%
Average
5.21%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Concord Medical Services Holdings Ltd | -- |
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 59.05% |
| Zai Lab Ltd | 61.66% |
| I-MAB | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -9.15% |
| Return on Invested Capital | -34.61% |
| Profit Margin (Quarterly) | -2.55% |
| Operating Margin (Quarterly) | -2.19% |
| Return on Net Operating Assets | -12.96% |